0001982875-25-000002.txt : 20251124
0001982875-25-000002.hdr.sgml : 20251124
20251124135427
ACCESSION NUMBER: 0001982875-25-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20251124
DATE AS OF CHANGE: 20251124
EFFECTIVENESS DATE: 20251124
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pelage Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001982875
ORGANIZATION NAME:
EIN: 824990957
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-564886
FILM NUMBER: 251511872
BUSINESS ADDRESS:
STREET 1: 907 WESTWOOD BLVD #384
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
BUSINESS PHONE: 949-244-9904
MAIL ADDRESS:
STREET 1: 907 WESTWOOD BLVD #384
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
D
1
primary_doc.xml
X0708
D
LIVE
0001982875
Pelage Pharmaceuticals, Inc.
907 WESTWOOD BLVD #384
LOS ANGELES
CA
CALIFORNIA
90024
949-244-9904
DELAWARE
None
None
Corporation
true
Daniel
Gil
907 Westwood Blvd., #384
Los Angeles
CA
CALIFORNIA
90024
Executive Officer
Director
William
Edward
Lowry
907 Westwood Blvd., #384
Los Angeles
CA
CALIFORNIA
90024
Executive Officer
Director
Nathan
Wheeler
907 Westwood Blvd., #384
Los Angeles
CA
CALIFORNIA
90024
Executive Officer
Cathy
Friedman
907 Westwood Blvd., #384
Los Angeles
CA
CALIFORNIA
90024
Director
Richard
Heyman
907 Westwood Blvd., #384
Los Angeles
CA
CALIFORNIA
90024
Director
Christina
Weng
907 Westwood Blvd., #384
Los Angeles
CA
CALIFORNIA
90024
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2025-09-18
false
true
false
0
119999987
119999987
0
false
5
0
0
0
true
false
Pelage Pharmaceuticals, Inc.
/s/Daniel Gil
Daniel Gil
Chief Executive Officer
2025-11-24